BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7899739)

  • 1. [Validation of a visual analog scale to measure dyspnea in patients with diffuse interstitial lung disease].
    Ramírez-Venegas A; Sansores Martínez RH; Carrillo Rodríguez G; Salas Hernández J; Chapela Mendoza R; Selman Lama M
    Rev Invest Clin; 1994; 46(6):479-86. PubMed ID: 7899739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
    Trad S; Amoura Z; Beigelman C; Haroche J; Costedoat N; Boutin le TH; Cacoub P; Frances C; Wechsler B; Grenier P; Piette JC
    Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of visual analog scale for assessment of dyspnea at rest in patients with chronic respiratory diseases].
    Yamada M; Akizawa T; Narushima M; Tanaka K; Suzuki H; Sibuya M; Kanamaru A; Homma I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):31-6. PubMed ID: 8114371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observation of rheumatoid arthritis associated interstitial lung disease patients and changes of serum cytokines thereof].
    Jian XD; Guo GR; Ruan YJ; Zhao B; Wang YC; Ning Q; Zhang YC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1884-7. PubMed ID: 19039999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
    Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
    J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual analogue scales for interstitial lung disease: a prospective validation study.
    Yates H; Adamali HI; Maskell N; Barratt S; Sharp C
    QJM; 2018 Aug; 111(8):531-539. PubMed ID: 29788503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of exercise tolerance in chronic bronchitis and interstitial lung disease.
    Mirchandani LV; Sharma RR; John PJ; Kolhatkar VP; Taskar VS; Mahashur AA
    J Assoc Physicians India; 1993 Mar; 41(3):144-6. PubMed ID: 8226596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
    Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
    J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyspnea in interstitial lung disease.
    Collard HR; Pantilat SZ
    Curr Opin Support Palliat Care; 2008 Jun; 2(2):100-4. PubMed ID: 18685404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of health-related quality of life decline in interstitial lung disease.
    Maqhuzu PN; Szentes BL; Kreuter M; Bahmer T; Kahn N; Claussen M; Holle R; Schwarzkopf L
    Health Qual Life Outcomes; 2020 Oct; 18(1):334. PubMed ID: 33032602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients.
    Shen M; Zhang F; Zhang X
    J Clin Gastroenterol; 2009 Aug; 43(7):676-9. PubMed ID: 19247207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the numeric rating scale as a measure of dyspnea.
    Gift AG; Narsavage G
    Am J Crit Care; 1998 May; 7(3):200-4. PubMed ID: 9579246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.
    Grau JM; Miró O; Pedrol E; Casademont J; Masanés F; Herrero C; Haussman G; Urbano-Márquez A
    J Rheumatol; 1996 Nov; 23(11):1921-6. PubMed ID: 8923367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab-induced interstitial lung disease.
    Wagner SA; Mehta AC; Laber DA
    Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.